Durham, NC, United States of America

Robert N Hunter


Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Robert N Hunter

Introduction

Robert N Hunter is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmacology, particularly through his work on oxindole derivatives. With a total of 2 patents, his inventions focus on addressing critical health issues related to cellular proliferation.

Latest Patents

Hunter's latest patents include "Substituted oxindole derivatives as tyrosine kinase inhibitors." This invention relates to oxindole derivatives that are useful pharmacologically as agents in disease states alleviated by the alteration of mitogen-activated signaling pathways. These compounds are particularly effective in inhibiting or antagonizing protein kinases involved in tumor growth, restenosis, atherosclerosis, pain, and thrombosis. The series of substituted oxindole compounds exhibit Trk family protein tyrosine kinase inhibition, making them valuable in cancer therapy and chronic pain management.

Career Highlights

Robert N Hunter is associated with SmithKline Beecham Corporation, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in medical treatments and therapies.

Collaborations

Hunter has collaborated with notable coworkers, including Lee Frederick Kuyper and Karen Elizabeth Lackey. These partnerships have likely enhanced the development and application of his inventions.

Conclusion

Robert N Hunter's contributions to the field of pharmacology through his innovative patents demonstrate his commitment to improving health outcomes. His work on oxindole derivatives showcases the potential for scientific advancements to address significant medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…